EMA Backs New Antibiotic for Complex Bacterial Infections Drishti Agarwal March 22, 2024

https://www.medscape.com/viewarticle/ema-backs-new-antibiotic-complex-bacterial-infections-2024a10005g1?src= The European Medicines Agency (EMA) has adopted a positive opinion for the marketing authorization of Emblaveo (aztreonam-avibactam), recommended for treating complicated intra-abdominal and urinary tract infections, hospital-acquired pneumonia, and infections stemming from specific types of bacteria (aerobic gram-negative) where therapeutic choices are restricted.